The Feasibility of Florbetapir Quantitation in Europe

Clinical trial NCT02107599 · COMPLETED

Trial details

NCT number: NCT02107599
Sponsor: Avid Radiopharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2014-03-01
Primary completion: 2014-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.